Inhibition of DMBA-induced mammary carcinogenesis in the rat by 2-br- -ergocryptine (CB 154), an inhibitor of prolactin secretion, and by nafoxidine (U-11, 100 A), an estrogen antagonist.

Authors :: Heuson JC
Waelbroeck C
Legros N
Gallez G
Robyn C
L'Hermite M
Source :: Gynecologic investigation [Gynecol Invest] 1971; Vol. 2 (1), pp. 130-7.
Publication Year :: 1971

Subjects :: Animals
Bromine pharmacology
Cell Transformation, Neoplastic
Estrus
Female
Mammary Neoplasms, Experimental drug therapy
Naphthalenes pharmacology
Ovary physiology
Pregnancy
Rats
Time Factors
Benz(a)Anthracenes
Ergot Alkaloids pharmacology
Estrogen Antagonists
Mammary Neoplasms, Experimental chemically induced
Phenols pharmacology
Prolactin metabolism
Pyrrolidines pharmacology

Full Text Access

Tools